AVEO Pharmaceuticals (AVEO) has an interesting forecast
AVEO Pharmaceuticals (AVEO) opened at $6.74, which means the stock is up 10.06% from yesterday’s closing price of 6.54. Today, the company has a high of $7.49 and a low of $6.53. The company has a market cap of $116.91 million with a 52-week high of $11.20 and a 52-week low of $2.23.
What about the future for AVEO Pharmaceuticals
The high forecast for AVEO Pharmaceuticals is 18.50 while the low is 6.00. Stock forecasts are based on human experience: Human traders based on their experience in terms of stock price patterns, volume changes, and market news/rumors regarding a particular stock. AVEO Pharmaceuticals has a weak forecast. A weak forecast is due to the company posting consistent losses in their earning reports. The future outlook does not seem too bright as this could potentially cause the company to file for bankruptcy.. Based on this information AVEO seems to be a risky buy.
About AVEO Pharmaceuticals
AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA.